circRNA from APP Gene Changes in Alzheimer's Disease Human Brain

被引:7
|
作者
Urdanoz-Casado, Amaya [1 ]
Sanchez-Ruiz de Gordoa, Javier [1 ,2 ]
Robles, Maitane [1 ]
Roldan, Miren [1 ]
Macias Conde, Monica [1 ,2 ]
Acha, Blanca [1 ]
Blanco-Luquin, Idoia [1 ]
Mendioroz, Maite [1 ,2 ]
机构
[1] Univ Publ Navarra UPNA, Navarra Inst Hlth Res, Neuroepigenet Lab Navarrabiomed, Complejo Hosp Navarra IdiSNA, Pamplona 31008, Navarra, Spain
[2] Complejo Hosp Navarra, IdiSNA Navarra Inst Hlth Res, Dept Neurol, Pamplona 31008, Navarra, Spain
关键词
Alzheimer's disease; entorhinal cortex; circRNA; mRNA; Amyloid beta; APP; AMYLOID PRECURSOR PROTEIN; CIRCULAR RNAS; NEUROPATHOLOGIC ASSESSMENT; EXPRESSION; BACE1; SCLEROSIS; PROFILES; ABUNDANT; MIR-186; EUROPE;
D O I
10.3390/ijms24054308
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) is the most common cause of age-related dementia. Amyloid precursor protein (APP) is the precursor of A beta peptides, and its role in AD has been widely investigated. Recently, it has been reported that a circular RNA (circRNA) originated from APP gene can serve as a template for A beta synthesis, postulating it as an alternative pathway for the A beta biogenesis. Moreover, circRNAs play important roles in brain development and in neurological diseases. Therefore, our aim was to study the expression of a circAPP (hsa_circ_0007556) and its linear cognate in AD human entorhinal cortex, a brain region most vulnerable to AD pathology. First, we confirmed the presence of circAPP (hsa_circ_0007556) in human entorhinal cortex samples using RT-PCR and Sanger sequencing of PCR products. Next, a 0.49-fold decrease in circAPP (hsa_circ_0007556) levels was observed in entorhinal cortex of AD cases compared to controls (p-value < 0.05) by qPCR. In contrast, APP mRNA expression did not show changes in the entorhinal cortex between AD cases and controls (Fold-change = 1.06; p-value = 0.81). A negative correlation was found between A beta deposits and circAPP (hsa_circ_0007556) and APP expression levels (Rho Spearman = -0.56, p-value < 0.001 and Rho Spearman = -0.44, p-values < 0.001, respectively). Finally, by using bioinformatics tools, 17 miRNAs were predicted to bind circAPP (hsa_circ_0007556), and the functional analysis predicted that they were involved in some pathways, such as the Wnt-signaling pathway (p = 3.32 x 10(-6)). Long-term potentiation (p = 2.86 x 10(-5)), among others, is known to be altered in AD. To sum up, we show that circAPP (hsa_circ_0007556) is deregulated in the entorhinal cortex of AD patients. These results add to the notion that circAPP (hsa_circ_0007556) could be playing a role in the pathogenesis of AD disease.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] COMPUTATIONAL APPROACH FOR DESIGNING AND DEVELOPMENT OF POTENT DRUG INHIBITOR FOR APP GENE IN ALZHEIMER'S DISEASE
    Behera, Santosh Kumar
    Behera, Ritesh Kumar
    Barik, Manas Ranjan
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (03): : 1099 - 1104
  • [42] Amyloid Precursor Protein Gene (APP) Variation in Late-Onset Alzheimer's Disease
    Miar, Ana
    Alvarez, Victoria
    Corao, Ana I.
    Diaz, Marta
    Alonso, Belen
    Martinez, Carmen
    Calatayud, Maria T.
    Menendez, Manuel
    Moris, German
    Coto, Eliecer
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2011, 45 (01) : 5 - 9
  • [43] Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues
    Muraoka, Satoshi
    DeLeo, Annina M.
    Sethi, Manveen K.
    Yukawa-Takamatsu, Kayo
    Yang, Zijian
    Ko, Jina
    Hogan, John D.
    Ruan, Zhi
    You, Yang
    Wang, Yuzhi
    Medalla, Maria
    Ikezu, Seiko
    Chen, Mei
    Xia, Weiming
    Gorantla, Santhi
    Gendelman, Howard E.
    Issadore, David
    Zaia, Joseph
    Ikezu, Tsuneya
    ALZHEIMERS & DEMENTIA, 2020, 16 (06) : 896 - 907
  • [44] Platelets and Alzheimer's disease: Potential of APP as a biomarker
    Evin, Genevieve
    Li, Qiao-Xin
    WORLD JOURNAL OF PSYCHIATRY, 2012, 2 (06): : 102 - 113
  • [45] The Role of the Urea Cycle in the Alzheimer's Disease Brain
    Al-Thani, Najlaa A.
    Stewart, Gavin S.
    Costello, Derek A.
    JOURNAL OF NEUROCHEMISTRY, 2025, 169 (03)
  • [46] APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targets
    Sirisi, Sonia
    Sanchez-Aced, Erika
    Belbin, Olivia
    Lleo, Alberto
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [47] Meprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer's disease
    Marengo, Liana
    Armbrust, Fred
    Schoenherr, Caroline
    Storck, Steffen E.
    Schmitt, Ulrich
    Zampar, Silvia
    Wirths, Oliver
    Altmeppen, Hermann
    Glatzel, Markus
    Kaether, Christoph
    Weggen, Sascha
    Becker-Pauly, Christoph
    Pietrzik, Claus U.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (03)
  • [48] Transmembrane and coiled-coil 2 associates with Alzheimer's disease pathology in the human brain
    Hopkins, Paul C. R.
    Troakes, Claire
    King, Andrew
    Tear, Guy
    BRAIN PATHOLOGY, 2025, 35 (01)
  • [49] Pooled analysis of frontal lobe transcriptomic data identifies key mitophagy gene changes in Alzheimer's disease brain
    Mei, Taoyu
    Li, Yuan
    Dolado, Anna Orduna
    Li, Zhiquan
    Andersson, Robin
    Berliocchi, Laura
    Rasmussen, Lene Juel
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 15
  • [50] Mosaic APP Gene Recombination in Alzheimer's Disease-What's Next?
    Lee, Ming-Hsiang
    Chun, Jerold
    JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2019, 13